⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EBS News
Emergent Biosolutions, Inc.
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
globenewswire.com
EBS
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
globenewswire.com
EBS
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
globenewswire.com
EBS
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
globenewswire.com
EBS
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
globenewswire.com
EBS
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
globenewswire.com
EBS